𝔖 Bobbio Scriptorium
✦   LIBER   ✦

The enhancer of zeste homolog 2 gene contributes to cell proliferation and apoptosis resistance in renal cell carcinoma cells

✍ Scribed by Nina Wagener; Daniela Holland; Julia Bulkescher; Irena Crnković-Mertens; Karin Hoppe-Seyler; Hanswalter Zentgraf; Maria Pritsch; Stephan Buse; Jesco Pfitzenmaier; Axel Haferkamp; Markus Hohenfellner; Felix Hoppe-Seyler

Publisher
John Wiley and Sons
Year
2008
Tongue
French
Volume
123
Category
Article
ISSN
0020-7136

No coin nor oath required. For personal study only.

✦ Synopsis

Abstract

The enhancer of zeste homolog 2 (EZH2) gene has been recently linked to human malignancies where it may serve as a new target for cancer therapy. Here, we analyzed EZH2 expression in primary renal cell carcinoma (RCC) specimens and in nontumorous tissue samples from adult kidney. EZH2 transcripts were detectable in all RCC specimens examined. Expression levels were significantly higher in tumor tissue (p ≤ 0.0001) than in samples from normal adult kidney. Moreover, inhibition of endogenous EZH2 expression in RCC cell lines by RNA interference (RNAi) led to reduced proliferation and increased apoptosis in RCC cells. These data show that EZH2 is overexpressed in RCC. Furthermore, they indicate that the EZH2 gene plays a role for both the proliferation and the apoptosis resistance of RCC cells. Targeted inhibition of EZH2 could therefore represent a novel strategy to improve the therapeutic response of RCC. © 2008 Wiley‐Liss, Inc.

📜 SIMILAR VOLUMES

Enhancement of TRAIL/Apo2L-mediated apop
Enhancement of TRAIL/Apo2L-mediated apoptosis by adriamycin through inducing DR4 and DR5 in renal cell carcinoma cells
✍ Xiu-Xian Wu; Yoshiyuki Kakehi; Youichi Mizutani; Hiroyuki Nishiyama; Toshiyuki K 📂 Article 📅 2003 🏛 John Wiley and Sons 🌐 French ⚖ 639 KB

## Abstract Renal cell carcinoma (RCC) is one of the most drug‐resistant malignancies in humans. We show that adriamycin (ADR) and TNF‐related apoptosis‐inducing ligand (TRAIL)/Apo2L have a synergistic cytotoxic effect against RCC cells. This synergistic cytotoxicity was obtained in ACHN, A704, Cak

Expression parameters of the inhibitors
Expression parameters of the inhibitors of apoptosis cIAP1 and cIAP2 in renal cell carcinomas and their prognostic relevance
✍ Carsten Kempkensteffen; Stefan Hinz; Frank Christoph; Jens Köllermann; Hans Krau 📂 Article 📅 2006 🏛 John Wiley and Sons 🌐 French ⚖ 226 KB

## Abstract The expression of the inhibitor of apoptosis (IAP) family members cIAP1 and cIAP2 have been shown to be altered in various cancer entities. This study was done to characterize the tumor‐related expression profile of cIAP1 and cIAP2 in patients with renal cell carcinomas (RCC) and to eva

Concomitant overexpression of the EGFR a
Concomitant overexpression of the EGFR and erbB-2 genes in renal cell carcinoma (RCC) is correlated with dedifferentiation and metastasis
✍ Gabriele Stumm; Stefanie Eberwein; Sandra Rostock-Wolf; Henning Stein; Siegfried 📂 Article 📅 1996 🏛 John Wiley and Sons 🌐 French ⚖ 686 KB

Gene amplification or structural alteration of different erbB genes exerts a transforming effect in a variety of human neoplasms. Overexpression of the EGF receptor is associated with tumor initiation and progression of renal cell carcinoma (RCC). However, the role of erbB-2 in these processes remai

Overexpression of interleukin-2 receptor
Overexpression of interleukin-2 receptor α in a human squamous cell carcinoma of the head and neck cell line is associated with increased proliferation, drug resistance, and transforming ability
✍ Deborah J. Kuhn; David M. Smith; Seth Pross; Theresa L. Whiteside; Q. Ping Dou 📂 Article 📅 2003 🏛 John Wiley and Sons 🌐 English ⚖ 349 KB 👁 1 views

## Abstract It has been previously demonstrated that human carcinomas express interleukin‐2 receptor (IL‐2R) α, β, and γ chains. The β and γ chains of IL‐2R have intermediate binding affinity for IL‐2 and are responsible for the intracellular signaling cascades after IL‐2 stimulation. IL‐2Rα lacks